Overview
Kelly Fitzgerald is a Radiation Oncologist practicing medicine in Boston, Massachusetts. She has been practicing medicine for over 10 years.
Dr. Fitzgerald is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
She is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital
Brian Alexander is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Alexander is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Mak is board certified in Radiation Oncology.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Kozono is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Kozono is board certified in Radiation Oncology.
Frequently Asked Questions about Dr. Kelly Fitzgerald
How do I make an appointment with Dr. Kelly Fitzgerald?
You can book an appointment with Dr. Kelly Fitzgerald by calling their office at 877-442-3324. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kelly Fitzgerald a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kelly Fitzgerald is classified as an Distinguished expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kelly Fitzgerald specialize in?
While Dr. Kelly Fitzgerald is a Radiation Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Kelly Fitzgerald participate in research or clinical trials?
Yes. Dr. Kelly Fitzgerald has published 31 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Kelly Fitzgerald's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kelly Fitzgerald accept my insurance?
Dr. Kelly Fitzgerald accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 877-442-3324 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Fitzgerald isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Fitzgerald isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Fitzgerald isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Fitzgerald isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Fitzgerald isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerDr. Fitzgerald isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Fitzgerald isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Fitzgerald isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Fitzgerald isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Lung NodulesDr. Fitzgerald isExperienced. Learn about Lung Nodules.
- Thymic Epithelial TumorDr. Fitzgerald isExperienced. Learn about Thymic Epithelial Tumor.
- Vulvar CancerDr. Fitzgerald isExperienced. Learn about Vulvar Cancer.